MJ
Martin H. Huber Jr.
President, CEODirector

Martin H. Huber Jr. insider trades: Mersana Therapeutics (MRSN) stock buys and sales

President, CEO, Mersana Therapeutics Last trade Sep 12, 2025 42 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2016
5
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Martin reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 12, 2025MRSN↓ Sell$15K
May 19, 2025SNDX↑ Buy$45K
Jan 16, 2025MRSN↓ Sell$3K
Sep 12, 2024MRSN↓ Sell$89K
Sep 24, 2018TSRO↓ Sell$14K
Mar 2, 2018TSRO↓ Sell$99K
Dec 4, 2017TSRO↓ Sell$71K
Sep 22, 2017TSRO↓ Sell$70K
Apr 3, 2017TSRO↓ Sell$127K
Mar 2, 2017TSRO↓ Sell$254K
Jan 3, 2017TSRO↓ Sell$26K
Nov 2, 2016TSRO↓ Sell$40K
Sep 22, 2016TSRO↓ Sell$44K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Martin H. Huber Jr.'s insider trades

Martin H. Huber Jr. is President, CEO at Mersana Therapeutics (MRSN). Since Sep 22, 2016, Martin has reported 1 open-market purchase worth $45K and 12 sales worth $850K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (32 filings), option exercises (10 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRSN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.